Du är här

2016-05-13

Ryhov County Hospital in Sweden acquires four C-RAD Systems

acquires four C-RAD Systems

Press release 2016-05-13

C-RAD has secured an order for three Catalyst HD™ systems and one Sentinel
4DCT™ system from Ryhov County Hospital in Jönköping, Sweden. The order has a
total value of 5.2 MSEK.

The Catalyst HD™ will be delivered with the complete software configuration
containing modules for Respiratory Gating, Patient Setup and Positioning, and
Motion Monitoring, as well as interfaces to the CT and the Varian TrueBeam®
linear accelerator. The customer also selected C-RAD’s unique audio-visual
couching functionality, which supports an interactive gating mode. Delivery and
installation of the order is scheduled for August, 2016.

The Catalyst HD™ and Sentinel™ systems enable the high-end treatment techniques
within radiation therapy that are increasingly common. With this dual solution
C-RAD supports the whole 4D treatment chain from imaging to treatment delivery.
Respiratory gated treatments are frequently used when the target volume is
close to cardiac tissue, or for special treatments in which the tumor position
depends on the respiratory cycle.

“It is a great pleasure to welcome the cancer center at Ryhov County Hospital
to the fast-growing group of C-RAD customers,” says Tim Thurn, CEO of C-RAD.
“Catalyst HD was developed specifically for the fast-growing segment of
Stereotactic Radiation Therapy (SBRT) and Stereotactic Radiosurgery (SRS), but
at the same time Catalyst HD provides the proven advantages of the Catalyst
system for treating breast cancer patients, as well as patients with other
indications. In this way, the clinic can utilize the full range of advantages
of surface tracking technology.”

About C-RAD

C-RAD develops innovative solutions for use in advanced radiation therapy. The
C-RAD group offers products and solutions for patient positioning, tumor
localization and radiation treatment systems. End users are radiation therapy
clinics worldwide. All product development is conducted in three fully owned
subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB and C-RAD Innovation AB,
all of which are located in Uppsala, Sweden. Employees currently number 43.
C-RAD’s business originates from research and development at Karolinska
Institutet in Solna, Sweden. Sales of the company’s first product, the C-RAD
Sentinel(TM), started in 2007. Cooperation agreements have been signed with
Elekta (Sweden), Varian (USA) and IBA (Belgium). C-RAD is represented by
distributors specialized in radiation therapy on major markets. C-RAD has
established three companies for direct sales: C-RAD Inc. in the US, C-RAD GmbH
in Germany and C-RAD WOFE in China. Cyrpa International SPRL, a Franco-Belgian
laser company, is a wholly owned subsidiary whose operations are being
integrated. C-RAD AB is listed on NASDAQ Stockholm.

For more information on C-RAD, please visit www.c-rad.com

For further information:

Tim Thurn, CEO C-RAD AB, Phone +46-18-666930, Email investors@c-rad.com

The above information is price-sensitive and must therefore be disclosed under
the Securities Market Act (2007:528).

Författare SSE

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.